United States · Series B startup

Who invested in Cognoa

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$85Mraised across 2 rounds since 2017, from 2 sources

$12MRound$73MSeries B
Latest round
Series B, $73MNov 2022
Step-upi
6.3×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201720182019202020212022
$12MRound$73MSeries B
First round
Round, $12M
Mar 2017
Biggest round
$73M
Series B · Nov 2022
Between rounds
5.6 years
from the last two

The rounds

  1. Nov 2022
    Series B$73M1 returning

    Source recorded

  2. Mar 2017
    Round$12M1 new

    Reported by FinSMEs

Everyone who backed them

Morningside GroupVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Cognoa as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Horizon Technology FinanceVenture debtPer its own site

Quick answers about Cognoa

Who invested in Cognoa?

Cognoa's investors include Morningside Group.

How much has Cognoa raised?

Cognoa has raised $85M across 2 rounds since 2017.

When did Cognoa last raise?

Cognoa's most recent round was a Series B of $73M in Nov 2022.

What was Cognoa's biggest round?

Its most recent round, $73M in Nov 2022, is also its largest on record.

Who backed Cognoa first?

Cognoa's first round on record, in Mar 2017, was backed by Morningside Group.

What stage is Cognoa at?

Cognoa's latest named round is a Series B, in Nov 2022.

Where is Cognoa based?

Cognoa is based in the United States.

Companies like Cognoa

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.